CytomX Therapeutics Inc (NASDAQ:CTMX)

5.39
BATS BZX Real-Time Price
As of 1:52pm ET
 +0.06 / +1.13%
Today’s Change
4.28
Today|||52-Week Range
10.05
-17.71%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$347.9M

Company Description

CytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multiple programs. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Contact Information

CytomX Therapeutics, Inc.
151 Oyster Point Boulevard
South San Francisco California 94080-1913
P:(605) 515-3185
Investor Relations:
(650) 273-4999

Employees

Shareholders

Other institutional50.72%
Mutual fund holders34.83%
Individual stakeholders23.52%

Top Executives

Sean A. McCarthyChairman, President & Chief Executive Officer
Carlos E. CampoyChief Financial Officer & Senior Vice President
Marcia P. BelvinSenior Vice President & Head-Research
Alison L. HannahChief Medical Officer & Senior Vice President
Amy C. PetersonChief Development Officer & Executive VP